Colletta Alessandro, Cooper Katherine M, Devuni Deepika
UMass Chan Medical School, 55 Lake Ave North, Worcester, MA 01655, USA.
UMass Chan Medical School, Worcester, MA, USA.
Therap Adv Gastroenterol. 2023 Jul 31;16:17562848231188813. doi: 10.1177/17562848231188813. eCollection 2023.
Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a complication of advanced liver disease in patients with ascites and circulatory dysfunction. Little data remain on the relationship between HRS-AKI outcomes and different etiologies of liver disease post-liver transplant (LT).
The primary aim was to evaluate the effect of HRS-AKI on renal outcomes in patients with acute alcohol-associated hepatitis (AAH) compared to chronic liver disease (CLD) after LT. The secondary aim was to evaluate the impact of acuity and chronicity of alcohol-associated liver disease in patients with HRS-AKI post-LT renal outcomes.
A retrospective observational study of patients undergoing urgent inpatient liver transplant evaluation (LTE) for cirrhosis and AAH at single academic LT center between October 2017 and July 2021 was conducted.
Patients with HRS-AKI were selected based on indication for LTE: acute AAH or CLD. CLD was categorized by disease etiology: cirrhosis due to alcohol (A-CLD) cirrhosis from other causes (O-CLD). CLD patients without HRS-AKI were labeled CLD.
A total of 210 subjects underwent LTE; 25% were evaluated for AAH and 75% were evaluated for CLD. Hepatorenal syndrome was more common in subjects evaluated for AAH (37/47) than CLD (104/163) (78.7 63.8%, = 0.04). For the primary outcome, AAH subjects required ⩾30 days post-LT renal replacement therapy (RRT) more often than subjects with CLD ( = 0.02) and CLD ( < 0.01). There was no significant difference in other forms of long-term renal outcomes including kidney transplant referral and kidney transplant among cohorts. In subgroup analysis, 30-days post-LT RRT was more common in AAH than in A-CLD ( = 0.08). Logistic regression showed that AAH conferred a 20× and 3.3× odds of requiring ⩾30 days post-LT RRT compared to CLD and CLD, respectively. Postoperative complications were similar across cohorts, but had a significant effect on 30-day renal outcome post-LT.
Patients with AAH were more likely to develop HRS and require RRT pre- and post-LT at our center. The etiology of hepatic decompensation and postoperative complications affect renal recovery post-LT. The systemic inflammation of AAH in addition to conditions favoring renal hypoperfusion may contribute to the unfavorable outcomes of HRS-AKI after LT in this patient population.
肝肾综合征 - 急性肾损伤(HRS - AKI)是腹水和循环功能障碍患者晚期肝病的一种并发症。关于肝移植(LT)后HRS - AKI结局与不同肝病病因之间的关系,现有数据较少。
主要目的是评估与LT后的慢性肝病(CLD)相比,HRS - AKI对急性酒精性肝炎(AAH)患者肾脏结局的影响。次要目的是评估LT后HRS - AKI患者中酒精性肝病的急性和慢性程度对肾脏结局的影响。
对2017年10月至2021年7月期间在单一学术性LT中心因肝硬化和AAH接受紧急住院肝移植评估(LTE)的患者进行了一项回顾性观察研究。
根据LTE指征选择HRS - AKI患者:急性AAH或CLD。CLD按疾病病因分类:酒精性肝硬化(A - CLD)、其他原因引起的肝硬化(O - CLD)。无HRS - AKI的CLD患者标记为CLD。
共有210名受试者接受了LTE评估;25%为AAH评估患者,75%为CLD评估患者。HRS在接受AAH评估的受试者中(37/47)比CLD受试者(104/163)更常见(78.7%对63.8%,P = 0.04)。对于主要结局,AAH受试者LT后需要肾脏替代治疗(RRT)≥30天的情况比CLD受试者(P = 0.02)和CLD(P < 0.01)更常见。各队列中包括肾移植转诊和肾移植在内的其他长期肾脏结局形式无显著差异。在亚组分析中,LT后30天RRT在AAH中比在A - CLD中更常见(P = 0.08)。逻辑回归显示,与CLD和CLD相比,AAH患者LT后需要≥30天RRT的几率分别高出20倍和3.3倍。各队列术后并发症相似,但对LT后30天肾脏结局有显著影响。
在我们中心,AAH患者更有可能发生HRS,并且在LT前后需要RRT。肝失代偿的病因和术后并发症影响LT后的肾脏恢复。除了有利于肾脏低灌注的情况外,AAH的全身炎症可能导致该患者群体LT后HRS - AKI的不良结局。